Holen Sie sich die Stockscreener-App
0.2518
1.68%
-0.0037
Schlusskurs vom Vortag:
$0.2555
Offen:
$0.26
24-Stunden-Volumen:
420.01K
Relative Volume:
0.12
Marktkapitalisierung:
$43.24M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-41.23M
KGV:
-0.3597
EPS:
-0.7
Netto-Cashflow:
$-11.54M
1W Leistung:
-13.38%
1M Leistung:
-13.05%
6M Leistung:
-65.45%
1J Leistung:
-58.83%
1-Tages-Spanne:
$0.2511
$0.2609
1-Wochen-Bereich:
$0.2404
$0.3032
52-Wochen-Spanne:
$0.2404
$2.10
Renovaro Inc Stock (RENB) Company Profile
Firmenname
Renovaro Inc
Sektor
Branche
Telefon
45 39179840
Adresse
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Vergleichen Sie RENB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RENB
Renovaro Inc
|
0.2512 | 59.70M | 0 | -41.23M | -11.54M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.99 | 118.67B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
570.25 | 59.23B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.06 | 52.67B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
691.23 | 41.24B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.36 | 32.36B | 3.81B | -644.79M | -669.77M | -6.24 |
Renovaro Inc Aktie (RENB) Neueste Nachrichten
What institutional investors are buying Renovaro Inc. stockTrack emerging stocks with high growth potential - Jammu Links News
Why is Renovaro Inc. stock attracting strong analyst attentionHigh-velocity gains - Jammu Links News
What are analysts’ price targets for Renovaro Inc. in the next 12 monthsOver 200% growth - Jammu Links News
What is Renovaro Inc. company’s growth strategyFree Consultation - Jammu Links News
How many analysts rate Renovaro Inc. as a “Buy”Achieve consistent high returns with low risk - Jammu Links News
What are Renovaro Inc. company’s key revenue driversCapitalize on market shifts with expert advice - Jammu Links News
Is Renovaro Inc. stock overvalued or undervaluedAchieve consistent double-digit growth rates - Jammu Links News
Is it the right time to buy Renovaro Inc. stockGet alerts on the hottest market movers - Jammu Links News
How does Renovaro Inc. compare to its industry peersFree Stock Movement Tracking - Jammu Links News
What makes Renovaro Inc. stock price move sharplyFree Investment Risk Control - Jammu Links News
How strong is Renovaro Inc. company’s balance sheetFree Stock Review For Consistent Profits - Jammu Links News
When is Renovaro Inc. stock expected to show significant growthPre Market Forecasts That Work - Jammu Links News
Why Renovaro Inc. stock attracts strong analyst attentionSwing Trading Entry Signals Suggest Opportunity Zone - beatles.ru
Candlestick Reversal Detected on Renovaro Inc.’s ChartWeekly Watchlist of High Movers Released - metal.it
AI Just Got a Green Light from the White House–Here’s What That Means for Healthcare Stocks - Cantech Letter
AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks - PR Newswire Canada
Is This a Bottoming Phase for Renovaro Inc.Wealth Building Stock Market Ideas Based on Momentum - beatles.ru
How did Renovaro's expenses impact profits in Q2 2025? - AInvest
Trading Bots Trigger Alerts on Renovaro Inc. ActivityReal Profit Trade Plan Suggestions Shared Widely - metal.it
Renovaro Inc. shares fall 1.59% after-hours following Maurice van Tilburg's resignation as chairman. - AInvest
Should I hold or sell Renovaro Inc. stock in 2025Daily Trading Review That Work - Jammu Links News
Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector - USA Today
Elliott Wave Theory Predicts Pullback in Renovaro Inc.Scalable Portfolio Growth Suggestions Released - metal.it
Renovaro BioSciences secures multiple U.S. patents in biomedical AI - TipRanks
Renovaro (RENB) Fortifies Position with New U.S. Patent Approvals - GuruFocus
Renovaro Bolsters Market Position with AI Patents in $20B Biomedical Sector - AInvest
Renovaro Multiple U.S. Patent Allowances To Bolster Biomedical AI Platform, Including Application No. 18/058,732 For Unbiased Drug Discovery Predictions - 富途牛牛
Renovaro Lands Game-Changing AI Patents for $20B Healthcare Market: Key Tech Details Revealed - Stock Titan
What are the latest earnings results for Renovaro Inc.Free Market Dynamics Reports - Jammu Links News
Competitive Positioning of Renovaro Inc.: Is It Leading or LaggingShort Term Profit Focus - metal.it
What are the technical indicators suggesting about Renovaro Inc.Capitalize on market trends before they peak - Jammu Links News
Renovaro chairman Maurice van Tilburg to step down in August By Investing.com - Investing.com UK
Renovaro chairman Maurice van Tilburg to step down in August - Investing.com Australia
Finanzdaten der Renovaro Inc-Aktie (RENB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
0.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):